STRONGBRIDGE BIOPHARMA PLC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure

On January 30, 2020, Strongbridge Biopharma plc issued a press release regarding new employment inducement awards.

The information contained in this Current Report on Form 8-K and Exhibit 99.1 is being furnished to the Commission and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report on Form 8-K and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits





Exhibit
Number                                 Exhibit Table

99.1        Press Release issued by Strongbridge Biopharma plc, dated January 30,
          2020  .






                                       2

© Edgar Online, source Glimpses